AI-generated summary
The authors randomized 93 adults with major depressive disorder and eveningness to 30 minutes daily of bright light therapy or dim red light placebo for five weeks, comparing diary and actigraphy sleep measures. They report that more severe depressive symptoms were associated with greater underestimation of total sleep time, and that bright light led to a greater advance in subjective sleep timing than placebo, with no group difference in actigraphic parameters.
- Participants
- 93
- Who or what was studied
- Adults with major depressive disorder and eveningness (non-seasonal)
- Limits stated in the abstract
- The abstract does not describe the full methods, and the group difference was found only for subjective sleep timing, not for objective actigraphy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Randomized controlled trial, Bright light therapy, Depression, Lux, Light-emitting diode, Red light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.